Academics affiliated with the University of Toronto are calling out the “purgatory” surrounding clinical cannabis research in Canada.
“Crucially, products sold in cannabis stores cannot be tested in human participants because commercial products do not meet the manufacturing requirements for research,” they write. “As a result, obtaining cannabis for research depends on the willingness, ability and good will of the cannabis industry to make research-grade products available, efforts that are unnecessary to sell product in the commercial market.”
The authors also note that this issue was highlighted in a letter signed by hundreds of scientists demanding changes in how clinical trials are regulated.
“Canada’s regulations effectively force academic-industry partnerships such that only research that industry finds acceptable can move forward,” the authors write, adding that some peer-reviewed funded studies have been cancelled for lack of research-grade and placebo products.
“Cannabis companies are
Read full article on The Growth Op
